# Glucose Response, Excursions And Treatment (GREAT) Study

> **NCT02506296** · NA · COMPLETED · sponsor: **Royal Devon and Exeter NHS Foundation Trust** · enrollment: 53 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** DPPIV inhibitor -
- **DEVICE:** Continuous glucose monitoring system.

## Key facts

- **NCT ID:** NCT02506296
- **Lead sponsor:** Royal Devon and Exeter NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2016-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506296, "Glucose Response, Excursions And Treatment (GREAT) Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02506296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*